share_log

Canaccord Genuity Downgrades Vicarious Surgical to Hold, Lowers Price Target to $0.4

Canaccord Genuity Downgrades Vicarious Surgical to Hold, Lowers Price Target to $0.4

Canaccord Genuity 将Vicarious Surgical的评级下调至持有,将目标股价下调至
Benzinga ·  2023/11/14 06:10

Canaccord Genuity analyst Caitlin Cronin downgrades Vicarious Surgical (NYSE:RBOT) from Buy to Hold and lowers the price target from $9 to $0.4.

Canaccord Genuity分析师凯特琳·克罗宁将Vicarious Surgical(纽约证券交易所代码:RBOT)的评级从买入下调至持有,并将目标股价从9美元下调至0.4美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发